Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Sciences research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.

For more information, please visit www.causaly.com

IRBM is an innovative contract research organization working across all aspects of drug discovery and early development for different modalities – small molecules, peptides, and antibodies. We foster collaborations with organizations from the pharmaceutical, biotech and academic sectors to accelerate drug discovery from target validation and hit identification to candidate nomination. Our 200 plus-strong, multidisciplinary teamwork at a state-of-the-art R&D facility near Rome where projects are carried out “under one roof” enabling rapid cycle times and close integration of the scientific teams. IRBM’s scientists have discovered several drugs that are on the market, and more than 25 compounds have gone into clinical testing. The company was founded in 2010, as a spin-off from Merck & Co. Now in our 14th year as an independent research organisation, we have laid the foundations to become a global centre for excellence in all aspects of drug discovery and early development.

IQVIA NLP unlocks and transforms your data, at scale, from bench to bedside. Our leading natural language processing platform is used by 19 of the top 20 pharma, as well as healthcare organizations and government, to uncover previously hard to reach information or replace manual extraction. Discover the true potential of your data with IQVIA NLP.

At Lonza Small Molecules, our connected experts work together to provide contract development and manufacturing services, helping pharma and small biotech companies deliver their medicines to patients in need. From the earliest stages of discovery to the final drug product, we can simplify your outsourcing experience with our reliable, timely service, anticipating risks and solving problems. Whether you are developing a pioneering therapy or creating a new oral solid dosage form, Lonza is the only CDMO partner you need. Throughout your molecule’s journey from early development to commercial product, we work as one.

Presude Lifesciences is a reputed CRO that provides end-to-end drug discovery services from target identification to lead optimization and identification of clinical candidates. Our extensive capabilities support stand-alone and integrated services in:

• Medicinal chemistry
• Custom synthesis / scale-up / process optimization
• Biological profiling
• ADME and toxicity profiling

At the heart of our success lie our exceptional scientists, who possess a mastery of transforming hits derived from screening or fragment-based techniques into promising drug-like molecules. Choose Presude Lifesciences as your catalyst for progress, and experience an expedited path from concept to clinical candidate identification. Together, we drive innovation, streamline drug discovery, and shape the future of healthcare.

If you are seeking a collaborative CRO partner to advance your drug discovery initiatives, we invite you to reach out to us: Mail@presude.com

Visit our website at www.presude.com to learn more about our services.

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated.

Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug development journey with well characterized in vitro and in vivo disease models in addition to general drug development services, providing valuable insights into the mode of action, pharmacokinetics, safety, and efficacy of investigational compounds. Our services are designed with personalized tailoring in mind, supported by innovative technical capabilities and are executed in close collaboration with our partners. With a focus on nephrology, immuno-oncology, neurology and cardiometabolic disease, our current models include a growing selection of genetic and induced disease models. InnoSer enhances these offerings by providing state-of-the-art imaging and digital pathology options, along with facility management and support services including colony management, cryopreservation, and sanitation/rederivation. We embrace innovation to meet the needs of our partners and the evolving industry. With a focus on proactive problem solving, we have proven ourselves to be a flexible and professional partner in the market. Together we create a smart road to better health.

Jubilant Biosys Limited (JBL), an integrated CRDMO and subsidiary of the Jubilant Pharmova family, which is one of the flagship companies of the Jubilant Bhartia Group. We offer end-to-end drug discovery services from our 3 R&D centres; Noida, Greater Noida and Bengaluru, while our manufacturing plant with multi-tonne capacity is in Nanjangud, India. With a strength of 1,000+ scientists, we accelerate drug discovery pipelines with seamless services from early Target Identification to Candidate Selection and further provide drug substance manufacturing support from late pre-clinical to commercial supplies. JBL has 7 plants and 18 streams including a pilot plant with reactor volumetric capacity of 900+ MTs, catering from kg to multi tonne (MTs) scale, for Intermediates & APIs. We adopt flexible business models, investments in new technologies, state-of-the-art infrastructure and have a global leadership pedigree to deliver excellence in small molecule drug discovery.

At VectorB2B we speed up your drug development program via CDMO/CRO integrated services delivered by a team of excellence.

Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. At Sterling we believe that whilst science can be complex, partnerships should be simple. That’s why we have redefined the CDMO experience with a partnership centred approach marked by transparency, collaboration and trust; a Partnership Development and Manufacturing Organisation (PDMO). Sterling has five facilities employing more than 1,300 people: its HQ in Cramlington, UK and a facility in Ringaskiddy, Ireland; two sites in the US, in Cary, North Carolina and Germantown, Wisconsin; and a dedicated bioconjugation and ADCs facility in Deeside, Wales.

For more information visit www.sterlingpharmasolutions.com

Merck KGaA, Darmstadt, Germany a vibrant science and technology company, with over 64,000 employees in 66 countries. Our advanced solutions and innovative technology are life-changing, influencing the research to creating a better tomorrow. We offer one of the broadest portfolios in the industry for scientists and our presence extends well beyond the labs as our innovations touch individuals around the world. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services, and expertise to perform experiments and engineer new products. This is where we begin our journey of collaboration with customers in academia, biomanufacturing and testing. For over 350 years, we have been at the forefront of technological and scientific advances, producing innovative products to demonstrate our dedication to drug discovery innovation. Our software for retrosynthesis Synthia™ and AIDDISON™ our AI-Powered Drug Discovery are just a couple of examples of our innovative solutions.

Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics—from discovery to delivery. Together, as Cytiva, we supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more.

Creative Biolabs provides professional custom service packages to fully meet client's specific needs in the drug development journey, especially for various antibody related modalities (monoclonal antibody, single domain antibody, bispecific antibody, multi-specific antibody, ADC, CAR T, etc.). Creative Biolabs generates antibodies against different targets ranging from hapten, soluble protein, membrane protein and whole cells, using well established multiple platforms such as hybridoma, phage display and B cell sorting for novel antibody discovery, enabling to provide the most suitable approach to the client's project. What makes Creative Biolabs distinguished from competitors is that we proceed with clients' projects according to their specific demands in quality, timeline and budget, supporting researchers across different therapeutic areas. Clear, open and regular communication with customers is as important to our success as our in-depth scientific knowledge. Having carved a unique niche by scripting many such success stories, Creative Biolabs' services are expanding from antibody discovery and development to a broader area. Immunotherapy, cell and gene therapy related technologies are our next areas of focus.

https://www.creative-biolabs.com/

Eurofins Advinus is a premier contract research organization (CRO) serving diverse industries to help advance their R&D programs within defined timelines with highest level of quality. We offer a complete suite of drug discovery, preclinical and early clinical development services. We offer standalone and integrated drug discovery services across various therapeutic areas and target classes. We have over a decade of drug discovery experience, with 35+ successful integrated programs and multiple assets in preclinical and clinical development. Our drug discovery services include Medicinal Chemistry, Analytical Chemistry, Discovery Biology and full range of ADME/DMPK studies. With 30+ years of GLP experience we strive to advance and accelerate your drug discovery programs cost-efficiently and with highly informed decisions towards the next critical milestone. We can help optimize your compound series with regards to different parameters – from target potency to ADME and safety properties.

Connect with us for more details bd@advinus.com

Sapio Sciences' mission is to improve life in the lab - because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware (TM) lab informatics platform combining cloud-based LIMS, ELN, and data solutions. Sapio serves some of the largest global and niche brands, including biopharma, CRO's and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, stability, clinical, histopathology, drug research, and in vivo studies. Our customers love Sapio's platform because it is robust, scalable, and with no-code configuration, can quickly adapt to meet unique needs.

Founded in 2020 by Leitat through the acquisition of the Drug Discovery & Preclinical Development centre of a Spanish pharmaceutical company, our goal is to become a tool of the global pharmaceutical research and innovation ecosystem by providing R&D pharma services and solutions to both pharma/biotech companies and partners in the public innovation sector, including academia, research centres and National Health Systems. Welab Barcelona is formed by experienced scientists with cutting-edge equipment and technologies, and a proven track record across the entire drug discovery and development cycle, successfully translating new discoveries into medicines. Welab is engaged in multiple collaborative research programs to discover new drugs to treat, among others, rare, neurologic and neurodegenerative diseases, pain, respiratory diseases, cancer, and infectious diseases. Welab’s R&D site, located in the Parc Científic of Barcelona (PCB), is the largest integrated Drug Discovery Centre in Spain (www.welabbarcelona.com).

Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers. Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering. Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms. With a focus on efficiency, innovation, and accessibility, Nostrum Biodiscovery is committed to providing cutting-edge solutions to the global scientific community.

From target identification to lead optimization and candidate selection, BioDuro-Sundia provides a broad range of discovery services with expertise and experience. Our extensive capabilities support stand-alone and integrated services in Chemistry, Biology, DMPK, Pharmacology, and pre-formulation development.

Core expertise includes small and large molecule discovery development and scale-up, support for IND/CTA submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The company has research sites and GMP manufacturing facilities in both the US and China. The one-stop-shop operation helps our partners across the globe to significantly accelerate discovery and de-risk development to create higher-value outcomes.

AseBio, the Spanish Bioindustry Association, bring together and represent the interests of companies, associations, foundations, universities, technology and research centers that work in the field of biotechnology in Spain. Since 1999, we have worked to achieve positive political and economic changes that promote and boost the development of the Spanish biotechnology industry. In order to do this, AseBio works closely with regional, national and European legislative bodies, as well as with all those social organisations that are committed to using biotechnology to improve citizens’ quality of life, environmental sustainability, economic development and skilled job creation. Our broad membership base and our extensive network of national and international collaborations make AseBio the key representative when it comes to designing policies and programmes for encouraging innovation, entrepreneurship and company development in the biotechnology industry, an undisputed vehicle for economic and social growth in Spain.

www.asebio.com

Healthcare Business Review is a print and digital magazine that reaches over 125,000 qualified subscribers in the U.S., consisting of senior-level Healthcare executives and corporate decision-makers from Hospitals, Health Systems, Homecare, physician Groups, Health Plans, and Managed Care Organizations. These qualified subscribers include executives like Chief Medical Officers, Administrative/ Business, Director/Managers, Medical Directors, Medical Waste Managers, and other executives from the Medical sector.

MedTech Outlook is a superlative podium for suppliers to showcase their products and services and healthcare industry professionals to connect with a global audience of decision-makers. Its unique learn-from-peer approach creates an immense impact in the U.S. market, adding a big difference in this continuously evolving medical tech arena. Learn more https://www.medicaltechoutlook.com/

Healthcare Tech Outlook is a print platform offering healthcare decision-makers critical information on adopting, innovating, and building new programs and approaches to enhance their capability to provide care. Healthcare Tech Outlook has been a pioneer in offering a learn-from-peer approach to the healthcare arena, offering technical advice to enhance both the overall healthcare landscape and assist individual care providers – from general practitioners and specialists to post-acute care organizations. Learn more http://healthcaretechoutlook.com/.

CIOReview is a leading technology magazine that is at the forefront of guiding enterprises through the continuously varying business environment with information about the solutions and services. The magazine serves as a trustworthy knowledge source as well as a platform for the C-suite executives, industry experts, technology buyers, and other decision-makers to share their valuable insights about new technology trends in the market. Learn more https://www.cioreview.com/.

Vydya Health: Find Providers, Products at vydya.com. Find providers from conventional, complementary and alternative care for professional help. Shop for wellness products at store.vydya.com. Join fellow providers, showcase your practice on https://www.vydya.com/.

CIO Applications Europe has fast culminated into the most sought-after magazine Pan-Europe as it has transformed its course hand-in-hand with the technology and has culminated into a leading media brand, with a unique editorial focus on bringing to light the core innovations in technology.CIO Applications Europe magazine stands out with its unique approach of learning from peers approach offering professionals the most comprehensive collection of technology trends. The magazine is the single most successful initiative of Pan-Europe to advise and guide decision-makers regarding the latest in the fast-evolving technology landscape. We are determined to propose a myriad of additional services that can improve businesses and help customers deal with issues related to this industry.

Home to CX since 2011, Customer Experience Magazine is your go-to place for industry news, best practices, and resources. Join us in building the largest community of CX professionals across the globe. Let transparency, quality, and connection shape our growth.

Cold Chain Platform (CCP) is 100% focused on cold chain and logistics in the bio-pharmaceutical, life science, and healthcare industries. CCP shares global cold chain and logistics information and valuable resources to help companies acting in the pharmaceutical space find the right cold chain and logistics partners for their supply chain management.

Website: www.coldchainplatform.com

The Industry Events platform enables collaboration between the world's professionals, enterprises, and academia through access to high-quality events and training across all industry sectors. Every day, new speaking, business and sponsorship opportunities are discovered through the global Industry Events website and app. The platform features thousands of the world’s top conferences, exhibitions, and online events as well as industry-relevant press releases and professional development courses. They specialize in promoting events within the realms of future tech, clean energy, pharma, maritime and fintech.

MEDizzy is the world’s fastest growing medical learning community. Together with their network of partners they educate over 10 million now and future healthcare professionals.They provide an innovative technology designed to enable quick and easy access to the latest medical knowledge. They offer a unique medical learning experience appreciated by HCPs from over 120 countries.".

B2B E-commerce information platform in the chemical industry around the world. They currently serve more than 10,000 suppliers and more than 70,000 buyers worldwide. They aim at helping their website buyers analyze the market and purchase high-quality chemicals, and in the meanwhile, assisting website suppliers to promote their superior products.

Exhibitors Voice is a platform that caters to all your service requirements in the B2B sector. You can rely on us to gather a good number of potential clients. In today's era, creating a digital impact is necessary. They have updated news, information, and opinions on the entire B2B segment through valuable contributions from individuals and corporations. The site is a valuable resource for multiple B2B requirements. They strive to serve the target audience's needs worldwide by giving a one- stop solution for resources from multiple industries. Your worthy contributions are given due credit and are acknowledged by advertising and content marketing opportunities. With Exhibitors Voice, you can do this in several ways, some marketing and advertising services that Exhibitors Voice provides are:

• You can contribute articles listing top event organizers
• Newsletters
• Email Marketing
• Webinar Marketing
• Social Media Marketing
• Banner marketing
• Virtual Event Marketing